Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

lenalidomide

  • Open Access
    Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone
    TAKESHI YOROIDAKA, TAKESHI YAMASHITA, RYOICHI MURATA, KYOKO YOSHIHARA, SATOSHI YOSHIHARA, MIKIO UEDA, SHINJI NAKAO, KOSEI MATSUE and HIROYUKI TAKAMATSU
    Anticancer Research January 2023, 43 (1) 157-165; DOI: https://doi.org/10.21873/anticanres.16145
  • You have access
    Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database
    JUNYA SATO, TSUCHIYA EREN, SAEKO MURATA, TADASHI SHIMIZU and MAYAKO UCHIDA
    Anticancer Research December 2022, 42 (12) 5917-5925; DOI: https://doi.org/10.21873/anticanres.16101
  • You have access
    Incorporating Bortezomib in the Management of Plasmablastic Lymphoma
    ONYEDIKA UMEANAETO, JOSEPH GAMBOA, JESUS DIAZ, M. NAWAR HAKIM, JAVIER CORRAL, ALEXANDER PHILIPOVSKIY and SUMIT GAUR
    Anticancer Research September 2019, 39 (9) 5003-5007; DOI: https://doi.org/10.21873/anticanres.13690
  • You have access
    Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?
    NATALIA KREINIZ, ALI KHATEEB, SHARON GINO-MOOR, AARON POLLIACK and TAMAR TADMOR
    Anticancer Research June 2016, 36 (6) 2889-2892;
  • You have access
    Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
    MICHAEL MIAN, MARTINA TINELLI, ELENA DE MARCH, GLORIA TURRI, VITTORIO MENEGHINI, NORBERT PESCOSTA, TAMARA BERNO, ALESSANDRA MARABESE, PATRIZIA MONDELLO, FRANCESCA PATRIARCA, GIOVANNI PIZZOLO, GIANPIETRO SEMENZATO, SERGIO CORTELAZZO and RENATO ZAMBELLO
    Anticancer Research March 2016, 36 (3) 1059-1065;
  • You have access
    Genes Involved in Maintaining the Bone Marrow Stroma Are Dysregulated in Patients with Myelofibrosis: Lenalidomide Treatment Up-regulates SOCS3
    ANA LIVUN, KATE J. NEWBERRY, TAGHI MANSHOURI, RAJKO KUSEC and SRDAN VERSTOVSEK
    Anticancer Research October 2015, 35 (10) 5219-5223;
  • You have access
    The Preclinical Activity of Lenalidomide in Indolent Urothelial Carcinoma
    WEIGUO JIAN, JONATHAN M. LEVITT, SETH P. LERNER and GURU SONPAVDE
    Anticancer Research July 2014, 34 (7) 3383-3389;
  • You have access
    Post-transplantation Consolidation and Maintenance Therapy with Lenalidomide for Japanese Patients with Multiple Myeloma
    HIROYUKI TAKAMATSU, SAORI MUNEMOTO, RYOICHI MURATA, YASUSHI TERASAKI, KENICHI NAKAJIMA and SHINJI NAKAO
    Anticancer Research December 2013, 33 (12) 5681-5685;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire